Hillhouse Capital Management - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
Hillhouse Capital Management ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$53,178,000
+29.9%
2,098,5810.0%1.70%
-0.6%
Q1 2019$40,922,000
+47.8%
2,098,5810.0%1.71%
-17.7%
Q4 2018$27,680,000
-64.0%
2,098,581
-51.5%
2.07%
+0.8%
Q3 2018$76,957,000
-19.2%
4,328,2890.0%2.06%
+26.7%
Q2 2018$95,222,000
+201.5%
4,328,289
+203.0%
1.62%
+191.4%
Q1 2018$31,586,000
+1.9%
1,428,5710.0%0.56%
+5.9%
Q4 2017$31,000,0001,428,5710.53%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders